Skip to main content
Mauna Kea Technologies logo

Mauna Kea Technologies — Investor Relations & Filings

Ticker · MKEA ISIN · FR0010609263 LEI · 5493007KMDG4MFIGJJ63 PA Manufacturing
Open in API
Filings indexed 774 across all filing types
Latest filing 2017-05-11 Annual Report
Country FR France
Listing PA MKEA

About Mauna Kea Technologies

https://www.maunakeatech.com/en/

Mauna Kea Technologies is a medical device company that develops and markets the Cellvizio® platform, a real-time in vivo cellular imaging system. The platform utilizes Confocal Laser Endomicroscopy (CLE) technology, enabling physicians to visualize tissue at the cellular level during medical procedures. This "optical biopsy" is performed using flexible, miniature fiber-optic probes (Confocal Miniprobes™) that are compatible with standard endoscopes. The core function of Cellvizio® is to provide immediate microscopic visualization, which aids in accelerating diagnosis, informing treatment strategies, and improving the precision of therapeutic interventions. Key applications include gastroenterology (for conditions such as Barrett's esophagus and pancreatic cysts), interventional pulmonology (lung cancer diagnostics), urologic oncology, and neurosurgery. The technology supports enhanced surgical procedures, including real-time margin assessment, and is being integrated with robotic surgery and AI-assisted imaging systems.

Recent filings

Filing Released Lang Actions
Rapport financier annuel
Annual Report Classification · 100% confidence The document is titled 'Rapport Financier Annuel 2015' (Annual Financial Report 2015) and contains a comprehensive summary including management reports, consolidated financial statements, audit reports, and corporate governance information for the fiscal year 2015. It is a full annual report, not an announcement or a summary, and meets the criteria for a 10-K equivalent in the French regulatory context. FY 2015
2017-05-11 French
Rapport financier annuel
Annual Report Classification · 100% confidence The document is titled 'Rapport Financier Annuel 2016' (Annual Financial Report 2016) for Mauna Kea Technologies. It contains a comprehensive summary, management reports (Rapport de gestion), consolidated financial statements (Comptes consolidés), annual accounts (Comptes annuels), and audit reports (Rapport des commissaires aux comptes). This structure is characteristic of a full Annual Report (10-K equivalent in the French market). FY 2016
2017-05-11 French
Communicated under the obligation to provide permanent information / Other communications
Regulatory Filings Classification · 95% confidence The document is a press release titled "MAUNA KEA TECHNOLOGIES ANNOUNCES STRONG PRESENCE AT DIGESTIVE DISEASE WEEK (DDW) 2017 CONFERENCE". It details company activities, presentations, and business model updates related to a medical conference. This type of announcement, which is not a formal regulatory financial filing (like 10-K, IR, or ER), but rather a general corporate update intended for investors and the public, fits best under the 'Regulatory Filings' (RNS) category as a general announcement, or potentially an Investor Presentation (IP) if it were the presentation itself. Since it is an announcement *about* presentations and activities, and not a core financial report, RNS serves as the most appropriate general disclosure category for non-standard announcements. It is not a Call Transcript (CT), Earnings Release (ER), or a formal financial report (10-K, IR). Given the context of a press release announcing participation and scientific findings, RNS is the best fit among the provided options for a general corporate update.
2017-05-09 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Regulatory Filings Classification · 95% confidence The document is a press release from Mauna Kea Technologies dated May 9, 2017, announcing their strong presence and the presentation of 27 clinical communications (oral presentations and posters) at the Digestive Disease Week (DDW) 2017 conference. It details specific presentations, quotes the CEO regarding clinical data adoption, and provides contact information for investor relations. This type of announcement, focusing on participation in a major industry conference and the presentation of clinical data, is typically classified as a general corporate announcement or press release. Since there is no specific category for 'Conference Participation Announcement' and it is not a formal regulatory filing (like 10-K, ER, or IR), the most appropriate fallback category is 'Regulatory Filings' (RNS), which often serves as a catch-all for significant, non-standard corporate news releases that are disseminated publicly. It is not an Earnings Release (ER) as it focuses on conference participation, not financial results. It is not an Investor Presentation (IP) as it is an announcement *about* presentations, not the presentation itself. Given the nature of the announcement (a press release about clinical data presentation at a medical conference), RNS is the best fit among the provided options.
2017-05-09 French
Quarterly financial report / First quarter financial report
Earnings Release Classification · 98% confidence The document is explicitly titled "MAUNA KEA TECHNOLOGIES REPORTS FIRST QUARTER 2017 SALES" and contains detailed financial figures (in € thousands) comparing Q1 2017 to Q1 2016, broken down by systems, consumables, services, and geography. This structure is characteristic of an initial announcement of periodic financial results, focusing on key highlights and figures rather than the comprehensive detail found in a full quarterly report (IR). The text also mentions hosting a conference call to review these results, which is typical for an Earnings Release (ER). It is not a full Annual Report (10-K), Audit Report (AR), or a comprehensive Interim Report (IR), as it only covers the first quarter and is presented as a press release announcing the figures. Q1 2017
2017-04-19 English
Information financière trimestrielle / Information financière du premier trimestre
Earnings Release Classification · 98% confidence The document explicitly announces the company's revenue for the first quarter ended March 31, 2017 ("annonce aujourd'hui son chiffre d'affaires pour le premier trimestre clos le 31 mars 2017"). It includes detailed financial tables comparing Q1 2017 results to Q1 2016, and management commentary on the period's performance. This structure is characteristic of an Earnings Release (ER), which provides the initial announcement of periodical financial results, often preceding a more comprehensive Interim Report (IR). Since it focuses on the quarterly results announcement and includes a call to discuss these results, 'ER' is the most appropriate classification. It is not a full, comprehensive Interim Report (IR) which usually contains full balance sheets and cash flows, nor is it a Call Transcript (CT) or a Management Discussion & Analysis (MDA) which is typically more narrative and forward-looking than this results summary. Q1 2017
2017-04-19 French

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.